In addition, higher expression of CALR is also associated with the more aggressive malignant processes and poorer prognosis in esophageal cancer [37], gastric cancer [7] and breast ductal carcinoma [44], which is also confirmed in our study. Here, CALR is linked to breast ductal adenocarcinoma.